Federal Funding for Infectious Diseases Programs

Today’s investment in ID research; public health and prevention; and development of new drugs, vaccines and diagnostics will pay significant dividends in the future. Such investments can prevent needless deaths, dramatically reduce health care costs, and improve the quality of life for millions of Americans and others around the world. IDSA supports appropriate funding for domestic and international programs including those at the:

National Institute for Allergies and Infectious Diseases
Centers for Disease Control and Prevention
Food and Drug Administration
Health Resources Services Administration
U.S. Agency for International Development
National Institute of Health’s Fogarty International Center

IDSA’s funding priorities include antimicrobial resistance; immunizations; drug, vaccine and diagnostics development; and HIV/AIDS and tuberculosis prevention and treatment.

IDSA's Efforts in Advocating for Appropriate Federal Funding for Infectious Diseases Programs

2/17/2012

IDSA Statement on President's FY 13 Budget Proposal

IDSA released a statement calling the President's FY 13 budget proposal a mixed bag for infectious diseases, making some crucial investments in the medical countermeasure (including antibiotic) development and infection control and prevention, while proposing flat funding for biomedical research and serious cuts to prevention, public health and immunization programs.

4/15/2011

IDSA Testimony on Fiscal Year 2012 Funding for Department of Health and Human Services (PDF)

IDSA submitted testimony to the House Appropriations Committee regarding FY 2012 funding for the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA).

4/23/2010

IDSA Testimony on Fiscal Year 2011 Funding for Department of Health and Human Services (PDF)

IDSA submitted testimony to the Senate Appropriations Subcommittee on Labor, Health and Human Services, and Education regarding FY 2011 funding for the Department of Health and Human Services (HHS). The testimony covers CDC, NIH and BARDA.

3/19/2010

IDSA Urges Increased Funding for FDA Antimicrobial Resistance Activities (PDF)

IDSA submitted testimony to the House Agriculture Appropriations Subcommittee urging a $20 million increase in antimicrobial resistance and antibacterial drug review programs at the Food and Drug Administration (FDA), as well as an increase for the new regulatory science initiative.

More Statements

5/7/2012

IDSA and HIVMA Defend the Prevention and Public Health Fund (PPHF) (PDF)

IDSA and HIVMA sent a joint letter urging congressional leaders to protect the PPHF and oppose any efforts to reduce or eliminate it, as the fund provides vital support for the preservation and promotion of our nation's public health, including building epidemiology and laboratory capacity, increasing immunization rates, preventing the spread of viral hepatitis, and reducing healthcare associated infections.

3/29/2012

IDSA Submits FY13 Appropriations Testimony (PDF)

IDSA highlighted its fiscal year (FY) 2013 funding priorities for health agencies, including the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), in testimony submitted to the House and Senate Labor, Health and Human Services, Education and Related Agencies Appropriations Subcommittees.

3/29/2012

IDSA Supports Funding for CDC's National Healthcare Safety Network (NHSN) and EpiCenters (PDF)

IDSA joined the Association for Professionals in Infection Control and Epidemiology, Council of State and Territorial Epidemiologists, Society for Healthcare Epidemiology of America, and Premier in a letter to Congress supporting increased funding for the NHSN and EpiCenters, which provide high quality tracking, monitoring and research on healthcare associated infections and antimicrobial resistant infections.

3/28/2012

IDSA Opposes Cuts to the Prevention and Public Health Fund

IDSA President Dr. Tom Slama joined the leaders of over 120 national organizations in a letter to President Obama expressing opposition to cuts to the Prevention and Public Health Fund, which has supported many important functions including building epidemiology and laboratory capacity to track and respond to disease outbreaks, modernizing vaccine systems, and preventing the spread of HIV/AIDS.

More Letters: U.S.

6/22/2011

Community Letter Advocating Robust Global Health Efforts (PDF)

IDSA joined 53 other organizations to urge lawmakers to maintain its funding commitments to improving health in developing countries, without cutting other broader humanitarian efforts and development or imposing any new policy restrictions.

11/5/2010

TB Coalition Letter for Global and Domestic TB Funding (PDF)

IDSA joined 16 other organizations to urge lawmakers to strengthen U.S. leadership in the fight against TB as envisioned in the Lantos-Hyde Act and Comprehensive TB Elimination Act by investing in global and domestic TB programs at USAID and CDC.